Norbert Lombriser Selected Research

Neoadjuvant Therapy

9/2013	Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer.
8/2009	Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norbert Lombriser Research Topics

Disease

6	Neoplasms (Cancer) 04/2020 - 11/2006
5	Carcinoma (Carcinomatosis) 04/2020 - 12/2004
2	Deglutition Disorders (Dysphagia) 01/2010 - 08/2009
2	Esophageal Neoplasms (Esophageal Cancer) 01/2010 - 08/2009
2	Prostatic Neoplasms (Prostate Cancer) 07/2007 - 11/2006
1	Anus Neoplasms (Anal Cancer) 04/2020
1	Adenocarcinoma 08/2009
1	Sarcoma (Soft Tissue Sarcoma) 01/2008
1	Aggressive Fibromatosis (Desmoid) 03/2007
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2004
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2004

Drug/Important Bio-Agent (IBA)

2	Protons (Proton)IBA 07/2007 - 11/2006
1	Cisplatin (Platino)FDA LinkGeneric 12/2004

Therapy/Procedure

6	Radiotherapy 04/2020 - 12/2004
3	Therapeutics 04/2016 - 07/2007
2	Chemoradiotherapy 04/2020 - 08/2017
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 04/2020 - 11/2006
2	Neoadjuvant Therapy 09/2013 - 08/2009
2	Induction Chemotherapy 01/2010 - 08/2009
1	Esophagectomy 08/2009
1	Drug Therapy (Chemotherapy) 08/2009
1	Conformal Radiotherapy 07/2007